Engineered andrographolide nanosystems for smart recovery in hepatotoxic conditions
Open Access
- 1 October 2014
- journal article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 9, 4723-4735
Abstract
Engineered andrographolide nanosystems for smart recovery in hepatotoxic conditions Partha Roy,1,2 Suvadra Das,1 Runa Ghosh Auddy,1,3 Arup Mukherjee1,3 1Division of Pharmaceutical and Fine Chemicals Technology, Department of Chemical Technology, University of Calcutta, Kolkata, India; 2Faculty of Technology (Pharmaceutical), Universiti Malaysia, Pahang, Malaysia; 3Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, Kolkata, India Andrographolide (AG) is one of the most potent labdane diterpenoid-type free radical scavengers available from plant sources. The compound is the principal bioactive component in Andrographis paniculata leaf extracts, and is responsible for anti-inflammatory, anticancer, and immunomodulatory activity. The application of AG in therapeutics, however, is severely constrained, due to its low aqueous solubility, short biological half-life, and poor cellular permeability. Engineered nanoparticles in biodegradable polymer systems were therefore conceived as one solution to aid in further drug-like applications of AG. In this study, a cationic modified poly(lactic-co-glycolic) acid nanosystem was applied for evaluation against experimental mouse hepatotoxic conditions. Biopolymeric nanoparticles of hydrodynamic size of 229.7±17.17 nm and ζ-potential +34.4±1.87 mV facilitated marked restoration in liver functions and oxidative stress markers. Superior dissolution for bioactive AG, hepatic residence, and favorable cytokine regulation in the liver tissues are some of the factors responsible for the newer nanosystem-assisted rapid recovery. Keywords: andrographolide, engineered nanosystems, poly(lactic-co-glycolic) acid, cytokine regulation, hepatotoxicityKeywords
This publication has 40 references indexed in Scilit:
- Efficient Hepatic Delivery of Drugs: Novel Strategies and Their SignificanceBioMed Research International, 2013
- Design, Synthesis, and Biological Evaluation of Andrographolide Derivatives as Potent Hepatoprotective AgentsChemical Biology & Drug Design, 2013
- Engineered Andrographolide Nanoparticles Mitigate Paracetamol Hepatotoxicity in MicePharmaceutical Research, 2013
- The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicityToxicology and Applied Pharmacology, 2012
- Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P‐glycoproteinJournal of Pharmaceutical Sciences, 2011
- Inhibition of TNF-α-Induced Inflammation by Andrographolide via Down-Regulation of the PI3K/Akt Signaling PathwayJournal of Natural Products, 2011
- Pharmacogenetics of Adverse Effects Due To Antiretroviral Drugs2010
- Delivery in vivo of 14-deoxy-11-oxoandrographolide, an antileishmanial agent, by different drug carriers.2003
- Research into complementary and alternative medicine: problems and potentialBMJ, 2001
- [Distribution and excretion of [35S]NaHSO3-andrographolide by autoradiography (author's transl)].1981